跳至主要内容
临床试验/ITMCTR2000003411
ITMCTR2000003411尚未招募4 期

Efficacy and safety of Zhenyuan capsule in improving the glucose metabolism of pre-diabetes patients:a randomized controlled trial

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Fasting venous blood glucose >=6.1 and < 7.0 mmol/L and / or 2 hours after meal venous blood glucose >=7.8 and <11.1 mmol/L;
  • 2. Patients aged 18-65 years;
  • 3. Patients with informed and voluntary consent.

排除标准

  • 1. The patients with type 2 diabetes were previously diagnosed;
  • 2. Patients who have participated in other clinical trials or received hypoglycemic drugs in the past 3 months;
  • 3. Patients with cardiovascular and cerebrovascular adverse events in the past 6 months;
  • 4. Patients with severe trauma, major infectious diseases, major organ functions or organic diseases and psychosis;
  • 5. Patients who are allergic to known components of the test drug;
  • 6. Women in pregnancy and lactation.

研究者

相似试验